UMIZORTAMIG
UNII KX8KZX98PB

Substance Identification & Data

This profile provides standardized clinical and technical data for Umizortamig, uniquely identified by the FDA Unique Ingredient Identifier (UNII) KX8KZX98PB.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2599198-83-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
KX8KZX98PB
CAS Registry Number
2599198-83-9
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
UMIZORTAMIG
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C203027
National Cancer Institute reference terminology for clinical and research data.
INN ID
12292
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Umizortamig. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

UMIZORTAMIG

Common Names & Synonyms

IMMUNOGLOBULIN SCFV-G1-SCFV-SCFV_L-KAPPA, ANTI-(HOMO SAPIENS EGFRVIII (EPIDERMAL GROWTH FACTOR RECEPTOR (RECEPTOR TYROSINE-PROTEIN KINASE ERBB-1, ERBB1, HER1, HER-1, ERBB) VARIANT III)), ANTI-(HOMO SAPIENS CD3E (CD3 EPSILON, LEU-4) AND CD3G), ANTI-(HOMO SAPIENS CD274 (PROGRAMMED CELL DEATH 1 LIGAND 1, B7H1, B7-H1, PDL1, PD-L1, PDCD1L1, B7 HOMOLOG 1, B7 HOMOLOGUE 1)) AND ANTI-(HOMO SAPIENS TNFRSF9 (TUMOR NECROSIS FACTOR RECEPTOR (TNFR) SUPERFAMILY MEMBER 9, 4-1BB, T CELL ANTIGEN ILA, CD137 (4-1BB, CD137). 41BB)), HUMANIZED AND CHIMERIC MONOCLONAL ANTIBODY, TETRASPECIFIC, TETRAVALENT
IMMUNOGLOBULIN, TETRASPECIFIC, ANTI-(HUMAN CD3 ANTIGEN .EPSILON.-CHAIN AND .GAMMA.-CHAIN) (HUMAN-ORYCTOLAGUS CUNICULUS CLONE 284A10 SINGLE-CHAIN VARIABLE FRAGMENT VL-(GGGGS)4-VH) FUSION PROTEIN WITH PEPTIDE LINKER (GGGGS)2 FUSION PROTEIN WITH IMMUNOGLOBULIN G1 ANTI-(HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR VARIANT III) (495-ALANINE,496-ALANINE,498-ALANINE,583-ALANINE,DE-707-LYSINE) (HUMAN-MUS MUSCULUS MONOCLONAL ABT-806 .GAMMA.1-CHAIN) FUSION PROTEIN WITH PEPTIDE LINKER (GGGGS)2 FUSION PROTEIN WITH IMMUNOGLOBULIN ANTI-(HUMAN PROGRAMMED DEATH-LIGAND 1) (HUMAN-ORYCTOLAGUS CUNICULUS CLONE PL221G5 SINGLE-CHAIN VARIABLE FRAGMENT VH-(GGGGS)4-VL) FUSION PROTEIN WITH PEPTIDE LINKER (GGGGS)2 FUSION PROTEIN WITH IMMUNOGLOBULIN ANTI-(HUMAN TUMOR NECROSIS FACTOR RECEPTOR TNFRSF9) (HUMAN-ORYCTOLAGUS CUNICULUS CLONE 420H5 SINGLE-CHAIN VARIABLE FRAGMENT VH-(GGGGS)4-VL), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL ABT-806 .KAPPA.-CHAIN, DIMER
UMIZORTAMIG [INN]

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus